The Role of Nutritional Supplements in the Treatment of ADHD: What the Evidence Says
- PMID: 28168597
- DOI: 10.1007/s11920-017-0762-1
The Role of Nutritional Supplements in the Treatment of ADHD: What the Evidence Says
Abstract
Attention-deficit hyperactivity disorder (ADHD) is a common behavioral disorder in children and adolescents and may persist into adulthood. Insufficient nutritional supply of long-chain polyunsaturated fatty acids (LC-PUFAs) and other components including various minerals has been suggested to play a role in the development of ADHD symptoms. This review presents the evidence regarding the role of nutritional PUFA, zinc, iron, and magnesium supplements in the treatment of ADHD with a focus on the critical evaluation of the relevant literature published from 2014 to April 2016. The evaluation of therapeutic nutritional LC-PUFA supplementation in ADHD has shown mixed and inconclusive results and at best marginal beneficial effects. The benefits of PUFAs are much smaller than the effect sizes observed for traditional pharmacological treatments of ADHD. The effectiveness of PUFA supplements in reducing medication dosage has been suggested but needs to be confirmed. Zinc, iron, and magnesium supplementation may reduce ADHD symptoms in children with or at high risk of deficiencies in these minerals. However, convincing evidence in this regard is lacking.
Keywords: ADHD; Iron; Magnesium; Nutritional supplements; Polyunsaturated fatty acids; Zinc.
References
-
- Prostaglandins Leukot Essent Fatty Acids. 2006 Oct-Nov;75(4-5):299-308 - PubMed
-
- Neurotoxicol Teratol. 2000 Sep-Oct;22(5):631-51 - PubMed
-
- Child Psychiatry Hum Dev. 2016 Apr;47(2):259-69 - PubMed
-
- Lancet. 2005 Jul 16-22;366(9481):237-48 - PubMed
-
- J Am Acad Child Adolesc Psychiatry. 2011 Oct;50(10):991-1000 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
